# S. Boulardii in Prevention of Antibiotic-associated Diarrhea in Hospitalized Adults With Respiratory Tract Infections

> **NCT05261152** · PHASE4 · COMPLETED · sponsor: **Clinical Centre of Serbia** · enrollment: 96 (actual)

## Conditions studied

- Prevention & Control
- Diarrhea Caused by Drug
- Respiratory Infection Bacterial
- Anti-Bacterial Agents

## Interventions

- **DRUG:** drug product: capsules are containing S. boulardii, administered twice daily (250 mg)

## Key facts

- **NCT ID:** NCT05261152
- **Lead sponsor:** Clinical Centre of Serbia
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-01
- **Primary completion:** 2018-12-01
- **Final completion:** 2018-12-31
- **Target enrollment:** 96 (ACTUAL)
- **Last updated:** 2022-03-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05261152

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05261152, "S. Boulardii in Prevention of Antibiotic-associated Diarrhea in Hospitalized Adults With Respiratory Tract Infections". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT05261152. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*